Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde 1/2005

01-02-2005 | Artikelen

Niet-invasieve markers bij inflammatoire darmziekten op de kinderleeftijd

Auteurs: G. M. Damen, E. E. S. Nieuwenhuis

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 1/2005

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Summary

Non-invasive markers of inflammation in blood or stool samples may be of help in children suspected of inflammatory bowel disease (ibd). Positive results will support the need for more invasive investigations, while some markers are of value in determining the type of ibd, as well as disease activity. Anemia and thrombocytosis are general indicators of ibd. Elevated erythrocyte sedimentation rate is often found in active Crohn's disease. In ibd colitis, asca and p-anca can be used in order to categorise the disease as either Crohn's disease or ulcerative colitis. The presence of these antibodies seems to be related to age of presentation, localisation of disease, results of treatment and outcome. Fecal alpha-1-antitrypsin is mainly increased in Crohn's disease, but is not clearly related to disease activity. Determination of fecal calprotectin in ibd seems to be more reliable, though in adults fecal calprotectin levels may be increased in colorectal carcinoma and nsaid-induced enteropathy. Fecal lactoferrin does not discriminate between Crohn's disease and ulcerative colitis, but is related to disease activity.
Literatuur
go back to reference Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004;89:69-71.PubMed Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004;89:69-71.PubMed
go back to reference Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child 1995;73:354-5.CrossRefPubMed Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child 1995;73:354-5.CrossRefPubMed
go back to reference Colombel JF, Reumaux D, Duthilleul P, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.PubMed Colombel JF, Reumaux D, Duthilleul P, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.PubMed
go back to reference Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002;8(5):325-9.CrossRefPubMed Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002;8(5):325-9.CrossRefPubMed
go back to reference Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134(4):447-52.CrossRefPubMed Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134(4):447-52.CrossRefPubMed
go back to reference Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115(4):822-9.CrossRefPubMed Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115(4):822-9.CrossRefPubMed
go back to reference Olives JP, Breton A, Hugot J-P, et al. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value. J Pediatr Gastroenterol Nutr 1997;25(2):142-8.CrossRefPubMed Olives JP, Breton A, Hugot J-P, et al. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value. J Pediatr Gastroenterol Nutr 1997;25(2):142-8.CrossRefPubMed
go back to reference Winter HS, Landers CJ, Winkelstein A, et al. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994;125(5 Pt 1):707-11.PubMed Winter HS, Landers CJ, Winkelstein A, et al. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994;125(5 Pt 1):707-11.PubMed
go back to reference Proujansky R, Fawcett PT, Gibney KM, et al. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;17(2): 193-7.PubMed Proujansky R, Fawcett PT, Gibney KM, et al. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;17(2): 193-7.PubMed
go back to reference Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.PubMed Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.PubMed
go back to reference Reumaux D, Sendid B, Duthilleul P, et al. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003;17:19-35.CrossRefPubMed Reumaux D, Sendid B, Duthilleul P, et al. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003;17:19-35.CrossRefPubMed
go back to reference Griffiths AM, Zachos M. Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody: clinical tools or clues for research? J Ped Gastroenterol Nutr 2000;30:1-2. Griffiths AM, Zachos M. Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody: clinical tools or clues for research? J Ped Gastroenterol Nutr 2000;30:1-2.
go back to reference Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431-6.CrossRefPubMed Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431-6.CrossRefPubMed
go back to reference Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006-9.CrossRefPubMed Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006-9.CrossRefPubMed
go back to reference Griffiths AM, Drobnies A, Soldin SJ, Hamilton JR. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents. J Ped Gastroenterol Nutr 1986;5(6):907-11.CrossRef Griffiths AM, Drobnies A, Soldin SJ, Hamilton JR. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents. J Ped Gastroenterol Nutr 1986;5(6):907-11.CrossRef
go back to reference Thomas DW, Sinatra FR, Merritt RJ. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease. J Ped Gastroenterol Nutr 1983;2(3):491-6.CrossRef Thomas DW, Sinatra FR, Merritt RJ. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease. J Ped Gastroenterol Nutr 1983;2(3):491-6.CrossRef
go back to reference Grill BB, Tinghitella T, Hillemeier C, Gryboski J. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease. J Ped Gastroenterol Nutr 1984;3(1):56-61.CrossRef Grill BB, Tinghitella T, Hillemeier C, Gryboski J. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease. J Ped Gastroenterol Nutr 1984;3(1):56-61.CrossRef
go back to reference Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001;7:460-5.PubMed Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001;7:460-5.PubMed
go back to reference Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Ped Gastroenterol Nutr 2001;32:171-7.CrossRef Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Ped Gastroenterol Nutr 2001;32:171-7.CrossRef
go back to reference Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Ped Gastroenterol Nutr 2001;33:14-22.CrossRef Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Ped Gastroenterol Nutr 2001;33:14-22.CrossRef
go back to reference Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50.CrossRefPubMed Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50.CrossRefPubMed
go back to reference Bjarnason I, Sherwood R. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation. J Ped Gastroenterol Nutr 2001;33:11-3.CrossRef Bjarnason I, Sherwood R. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation. J Ped Gastroenterol Nutr 2001;33:11-3.CrossRef
go back to reference Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14.CrossRefPubMed Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14.CrossRefPubMed
go back to reference Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: sensitive marker for monitoring inflammatory bowel disease in pediatric patients [abstract]. J Pediatr Gastroenterol Nutr 2002;34(4):466. Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: sensitive marker for monitoring inflammatory bowel disease in pediatric patients [abstract]. J Pediatr Gastroenterol Nutr 2002;34(4):466.
Metagegevens
Titel
Niet-invasieve markers bij inflammatoire darmziekten op de kinderleeftijd
Auteurs
G. M. Damen
E. E. S. Nieuwenhuis
Publicatiedatum
01-02-2005
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 1/2005
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061588

Andere artikelen Uitgave 1/2005

Tijdschrift voor Kindergeneeskunde 1/2005 Naar de uitgave

Boekbespreking

Boekbespreking